These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31578757)

  • 1. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
    Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
    Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
    Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
    Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
    Nyazika TK; Hagen F; Meis JF; Robertson VJ
    J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
    Hurtado JC; Castillo P; Fernandes F; Navarro M; Lovane L; Casas I; Quintó L; Marco F; Jordao D; Ismail MR; Lorenzoni C; Martinez-Palhares AE; Ferreira L; Lacerda M; Monteiro W; Sanz A; Letang E; Marimon L; Jesri S; Cossa A; Mandomando I; Vila J; Bassat Q; Ordi J; Menéndez C; Carrilho C; Martínez MJ
    Sci Rep; 2019 May; 9(1):7493. PubMed ID: 31097746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
    Chan M; Lye D; Win MK; Chow A; Barkham T
    Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
    Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.
    Cheng PY; Sham A; Kronstad JW
    Infect Immun; 2009 Oct; 77(10):4284-94. PubMed ID: 19635827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.
    Cogliati M; Puccianti E; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Rickerts V; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencà ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Boekhout T; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Colom MF
    Environ Microbiol; 2017 Oct; 19(10):4318-4325. PubMed ID: 28892309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus gattii: a resurgent fungal pathogen.
    Chaturvedi V; Chaturvedi S
    Trends Microbiol; 2011 Nov; 19(11):564-71. PubMed ID: 21880492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten challenges on Cryptococcus and cryptococcosis.
    Del Poeta M; Casadevall A
    Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes and population genetics of cryptococcus neoformans and cryptococcus gattii species complexes in Europe and the mediterranean area.
    Cogliati M; Desnos-Ollivier M; McCormick-Smith I; Rickerts V; Ferreira-Paim K; Meyer W; Boekhout T; Hagen F; Theelen B; Inácio J; Alonso B; Colom MF; Trilles L; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencá ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Pasquale V; Polacheck I; Lockhart SR
    Fungal Genet Biol; 2019 Aug; 129():16-29. PubMed ID: 30953839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What makes Cryptococcus gattii a pathogen?
    Bielska E; May RC
    FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of Cryptococcus Meningoencephalitis].
    Miyazato A
    Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
    Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
    mBio; 2012; 3(3):. PubMed ID: 22570277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.